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Abstract 
The “bivalent domain,” a distinctive histone modification signature, is characterized by 
repressive trimethylation of histone H3 at lysine 27 (H3K27me3) and active 
trimethylation of histone H3 at lysine 4 (H3K4me3) marks. Maintenance and dynamic 
resolution of these histone marks play important roles in regulating differentiation 
processes in various stem cell systems. However, little is known regarding their roles in 
hepatic stem/progenitor cells. In the present study, we conducted the chromatin 
immunoprecipitation (ChIP) assay followed by high-throughput DNA sequencing (ChIP-
seq) analyses in purified delta-like 1 protein (Dlk)+ hepatic stem/progenitor cells and 
successfully identified 562 genes exhibiting bivalent domains within 2 kb of the 
transcription start site. Gene Ontology analysis revealed that these genes were enriched 
in developmental functions and differentiation processes. Microarray analyses indicated 
that many of these genes exhibited de-repression after differentiation toward hepatocyte 
and cholangiocyte lineages. Among these, 72 genes, including Cdkn2a and Sox4, were 
significantly upregulated after differentiation toward hepatocyte or cholangiocyte 
lineages. Knockdown of Sox4 in Dlk+ cells suppressed colony propagation and resulted 
in increased numbers of albumin+/cytokeratin 7+ progenitor cells in colonies. These 
findings implicate that de-repression of Sox4 expression is required to induce normal 
differentiation processes. In conclusion, combined ChIP-seq and microarray analyses 
successfully identified bivalent genes. Functional analyses of these genes will help 
elucidate the epigenetic machinery underlying the terminal differentiation of hepatic 
stem/progenitor cells. 
 
1. Introduction 
Before 2000, most research on liver development and differentiation was performed using 
morphological approaches in knockout mice [1]. Thus, many transcription factors with 
important roles in hepatocyte and cholangiocyte differentiation have been reported [2,3]. 
Advances in cell sorting technology since the beginning of the 21st century have led to 
progress in the isolation and identification of hepatic stem/progenitor cells [4], and it has 
become possible to analyze signal transduction pathways and molecules involved in the 
maintenance and/or differentiation of stem cells [5-7]. 
Epigenetic mechanisms, including DNA methylation and histone modification, are 
essential for cell fate decisions and differentiation during embryogenesis [8]. Particularly, 
histone modifications are dynamically regulated by enzymes that add or remove these 
modifications [9], and these modifications have been described as extremely important in 
developmental processes in both the liver and pancreas [10]. Although polycomb group 
(PcG) proteins are responsible for transcription-repressive histone H3 trimethylation at 
lysine 27 (H3K27me3), trithorax group complexes (TrxG) are associated with 
transcription-active histone H3 trimethylation at lysine 4 (H3K4me3) [11]. In embryonic 
stem (ES) and tissue-specific stem cells, the promoter regions of genes that regulate 
differentiation contain “bivalent domains” with both the H3K27me3 and H3K4me3 [12]. 
This configuration is believed to allow cell fate determination and differentiation to 
rapidly begin in any direction in response to intracellular and extracellular signals. 
Here, we aimed to elucidate the mechanisms through which histone modifications 
regulate differentiation from the viewpoint of bivalent domains in normal hepatic 
stem/progenitor cells. We performed the chromatin immunoprecipitation (ChIP) assay 
followed by high-throughput DNA sequencing (ChIP-seq) analyses in delta-like 1 protein 
(Dlk)+ hepatic stem/progenitor cells using anti-H3K4me3 and anti-H3K27me3 antibodies. 
Next, we performed microarray analyses using RNA isolated from Dlk+ and differentiated 
cells. A comprehensive analysis of these data allowed for determination of bivalent genes 
and elucidation of epigenetic regulatory machinery of differentiation process in hepatic 
stem/progenitor cells. 
 
 
2. Materials and Methods 
 
2.1. Mice 
Pregnant C57BL/6 mice were purchased from Japan SLC (Hamamatsu, Japan). They 
were bred and maintained in accordance with our institutional guidelines for the use of 
laboratory animals. 
 
2.2. Purification and culture of Dlk+ cells 
Dlk+ cells were prepared from embryonic day (ED) 14.5 fetal livers, as described 
previously [13]. Briefly, cells were stained with anti-Dlk antibody (MBL, Nagoya, Japan) 
followed by exposure to anti-rat IgG-conjugated magnetic beads (Miltenyi Biotec, 
Bergisch Gladbach, Germany). Dlk+ cells were corrected by passing them through cell 
separation columns under a magnetic field (Miltenyi Biotec).  
 
2.3. Colony assays and terminal differentiation experiments 
Dlk+ cells (1×103 cells/well) were plated on collagen type IV-coated 6-well plates (Becton 
Dickinson, Franklin lakes, NJ) and cultured as described elsewhere [13]. At least three 
independent triplicate experiments were performed for colony assays. To evaluate the 
ability to differentiate into hepatocytes, Dlk+ cells were placed on an Engelbreth–Holm–
Swarm (EHS) gel (Becton Dickinson) in the presence of oncostatin M (OSM, R&D 
Systems, Minneapolis, MN). Similarly, the cells were placed on collagen type I gel (Nitta 
Gelatin, Osaka, Japan) in the presence of tumor necrosis factor (TNF)-α (Peprotech, 
Rocky Hill, NJ) to examine their potential to differentiate into cholangiocytes. 
 
2.4. Flow Cytometry 
To examine the purity of Dlk+ cells sorted by magnetic cell separation, the cells were 
stained with phycoerythrin (PE)-conjugated anti-Dlk antibody (MBL). Propidium iodide 
(1 µg/ml) was added for the elimination of dead cells. Cell analysis and sorting were 
performed using FACSCanto and FACSAria II (BD Biosciences, San Jose, CA). 
 
2.5. Immunocytochemistry  
Colonies derived from Dlk+ cells were stained with rabbit anti-albumin (Alb) (GeneTex, 
San Antonio, TX) and mouse anti-cytokeratin 7 (CK7) (DakoCytomation, Fort Collins, 
CO) antibodies followed by Alexa Fluor 555-conjugated goat anti-rabbit IgG (Molecular 
Probes, Eugene, OR) and Alexa Fluor 488-conjugated goat anti-mouse IgG (Molecular 
Probes) antibodies, respectively. The absolute number of Alb+CK7+ bipotent cells in each 
large colony at day 5 of culture was determined in at least 10 large colonies containing 
containing >100 cells. 
 
2.6. Reverse transcription-polymerase chain reaction (RT-PCR) 
RNA was extracted using RNeasy Mini kit (Qiagen, Valencia, CA), following the 
manufacturer protocol. Quantitative RT-PCR was performed with an ABI PRISM 7300 
Sequence Detection System (Applied Biosystems, Foster City, CA) using the Universal 
Probe Library System (Roche Diagnostics, Mannheim, Germany) following the 
manufacturer protocol. The primer sequences are listed in Supplementary Table S1. 
 
2.7. Lentiviral production and transduction 
Lentiviral vectors (CS-H1-shRNA-EF-1a-EGFP) expressing short hairpin RNA (shRNA) 
that targets murine Sox4 (target sequence: sh-Sox4-1, 5′-
ACCAACAACGCGGAGAACACT-3′; sh-sox4-2, 5′-
GCGACAAGATTCCGTTCATCA-3′), and luciferase (Luc) were constructed. 
Recombinant lentiviruses were produced as described previously [14]. 
 
2.8. Western blotting  
Sox4-knockdown cells were selected via cell sorting for enhanced green fluorescent 
protein (EGFP) expression. The cells were subjected to Western blotting using anti-Sox4 
(Santa Cruz Biotechnologies, Santa Cruz, CA) and anti-Tubulin (Oncogene Science, 
Cambridge, MA) antibodies.  
 
2.9. Chromatin immunoprecipitation 
Chromatin immunoprecipitation (ChIP) was performed as described previously [15].  
Briefly, cross-linked chromatin was sonicated into 200–500-base-pair fragments. The 
immunoprecipitated and input DNA was treated using anti-H3K4me3 (Millipore, Bedford, 
MA, USA) and anti-H3K27me3 antibodies (Millipore). Normal mouse IgG was used as 
a negative control. The immunoprecipitated and input DNA was treated with RNase A 
(Sigma-Aldrich) and proteinase K (Roche) and purified using the QIAquick PCR 
purification kit (Qiagen). Quantitative PCR was conducted using the ABI Prism 7300 
Thermal Cycler with SYBR Premix Ex Taq II (Takara Bio, Otsu, Japan). The primer 
sequences used are listed in Supplementary Table S2. 
 
2.10. ChIP-sequence analysis 
The reads per million (RPM) mapped read values of the region from 2 kb upstream to 2 
kb downstream to the transcription start site (TSS) of the immunoprecipitated samples 
were divided by the RPM of the corresponding input. The RPM values of the sequenced 
reads were calculated every 2,000-base-pair bins with a shifting size of 200 base pairs 
using bedtools. The RPM values of the sequenced read were calculated using BEDTools. 
The RPM values of the sequenced reads were calculated using BEDTools and visualized 
using the Integrative Genomics Viewer (http://www.broadinstitute.org/igv). The ChIP-
seq data obtained in this study were deposited in DNA Data Bank of Japan (DDBJ, 
accession number DRA006858). 
 
2.11. Microarray analysis 
Microarray analysis was conducted using SurePrint G3 Mouse GE microarray (Agilent 
Technologies, Santa Clara, CA, USA). The microarray was labeled, hybridized, washed, 
and scanned as described by the manufacturer. The expression value (signal) for each 
probe set was calculated using GeneSpring GX 12.0 (Agilent). Data were normalized 
using GeneSpring normalization algorithms (Agilent). Only statistically significant gene 
expression levels (P < 0.05) were recorded as being “detected” above background levels, 
whereas genes with expression levels lower than this statistical threshold were considered 
“absent.” To identify differentially expressed genes involved in the differentiation of Dlk+ 
cells, genes exhibiting greater than 2.0-fold changes were selected. Moreover, gene 
ontology (GO) annotations were performed using the GeneSpring annotation tool 
(Agilent). The significance of each term was determined using Fisher’s exact test and the 
Bonferroni adjustment for multiple testing. The raw data are available at Gene Expression 
Omnibus (GEO, accession number; GSE 114833). 
 
2.12. Statistical analysis 
Data are presented as the mean ± SEM. Statistical differences were analyzed using the 
Mann-Whitney U test. The correlation between histone marks and expression levels was 
analyzed using Pearson's correlation analysis. P values less than 0.05 were considered 
significant. 
3. Results 
 
3.1. Genome-wide analyses of H3K4me3 and H3K27me3 in hepatic stem/progenitor cells 
To gain an insight into the histone modification of hepatic stem/progenitor cells, we 
purified Dlk+ cells from fetal livers at ED 14.5 using magnetic activated cell sorting 
(MACS). Flow cytometric analysis revealed that the purity of the sorted Dlk+ cells was 
approximately 90% (Supplementary Figure S1). To explore the genome-wide distribution 
of H3K4me3 and H3K27me3 in hepatic stem/progenitor cells, purified Dlk+ cells were 
subjected to ChIP-seq analysis. Although both the H3K4me3 and H3K27me3 peaks were 
observed in the slight downstream region of TSS, the H3K27me3 peaks had greater width 
and centrally-depressed signals (Figure 1(a)). We focused on the region within 2.0 kb of 
the TSSs of the reference sequence genes (Figure 1(b)). Subsequently, ChIP-seq analysis 
successfully identified 9,687 genes with H3K4me3 enrichment and 1,151 genes with 
H3K27me3 enrichment greater than 2-fold (log2) of the input levels. Totally, 562 genes 
possessed bivalent chromatin domains containing H3K4me3 and H3K27me3 marks 
(Figure 1(c)). 
We subsequently compared the list of these genes with the ChIP-seq data examined in 
mouse ES cells and human/mouse hematopoietic stem cells (HSCs) [16,17]; 26 and 10 
genes with bivalent promoters in hepatic stem/progenitor cells were overlapped with 
bivalent genes in ES cells and HSCs, respectively (Figure 1(d)). Among them, three genes, 
namely Ebf1, Pax6, and HoxA1, were overlapped with genes with bivalent promoters in 
both ES cells and HSCs. To gain insights into their biological roles, we analyzed the 562 
identified bivalent genes. Functional annotations based on GO revealed significant 
enrichment of genes belonging to the categories “DNA binding,” “transcription,” 
“development,” and “differentiation” (Figure 1(e)). 
 
3.2. Comparison between histone marks and gene expression levels 
Initially, based on the microarray data of freshly purified Dlk+ cells, we examined the 
relationship between histone modification patterns and gene expression levels (Figure 
2(a)). Pearson’s correlation coefficient analysis revealed a positive correlation between 
gene expression and H3K4me3 levels (r = 0.57) and a negative correlation between gene 
expression and H3K27me3 levels (r = −0.24). We compared expression levels among 
genes marked with H3K4me3, H3K27me3, and both H3K4me3 and H3K27me3 
(bivalent) (Figure 2(b)). Genes with H3K4me3 marks showed higher expression levels, 
whereas those with H3K27me3 marks and bivalent marks (H3K4/27me3) displayed 
lower expression levels.  
 3.3 Identification of bivalent genes showing de-repression during differentiation 
Next, we cultured Dlk+ cells on EHS gel in the presence of OSM to induce differentiation 
into mature hepatocytes and on collagen type I gel in the presence of TNF-α to selectively 
induce differentiation into cholangiocytes. mRNA extracted from these differentiated 
cells was subjected to microarray analysis. We successfully identified 2,724 upregulated 
and 2,844 downregulated genes after the differentiation of Dlk+ cells into hepatocytes 
(Figure 2(c)). Similarly, 2,852 genes were upregulated and 2,799 were downregulated 
after differentiation into cholangiocytes. Bivalent domains are considered to control the 
expression of developmental genes, thus allowing timely activation during the 
differentiation process. To gain insights into epigenetic differentiation regulators, we 
highlighted the bivalent genes that were de-repressed following the differentiation of 
hepatic stem/progenitor cells. As a result, 128 and 115 genes were upregulated during 
differentiation into hepatocytes and cholangiocytes, respectively (Figure 2(d)). Among 
these, 72 genes were commonly upregulated during differentiation toward both the 
hepatocyte and cholangiocyte lineages (Supplementary Table S3). 
 
3.4. Changes of histone marks in Ink4a/Arf gene locus during differentiation 
Among the bivalent genes, the Ink4a/Arf locus was modified by bivalent histone marks 
in purified Dlk+ cells. Ink4a/Arf is an important target of PcG, and its transcriptional 
repression is essential for maintaining self-renewal in hepatic stem/progenitor cells [18]. 
Consistent with microarray data, real-time PCR analyses demonstrated that remarkable 
de-repression of Ink4a/Arf was observed after the induction of hepatocytic and 
cholangiocytic differentiation (Supplementary Figure S2). ChIP analyses revealed high 
levels of both H3K4me3 and H3K27me3 marks at the Ink4a/Arf promoter in purified Dlk+ 
cells. However, H3K27me3 levels, but not H3K4me3 levels, were diminished at the locus 
in mature hepatocytes and cholangiocytes 
 
3.5. Bivalent histone modification on the Sox4 gene locus 
Similar to Ink4a/Arf, SRY-related HMG box 4 (Sox4) exhibited bivalent loci in purified 
Dlk+ cells (Figure 3(a)). Real-time PCR analyses demonstrated that Sox4 was 
significantly upregulated after differentiation toward the hepatocyte and cholangiocyte 
lineages (Figure 3(b)). Sox4 upregulation was more prominent in cholangiocytes than in 
hepatocytes. We next focused on the role of Sox4 in hepatic stem/progenitor cells. Sox4 
upregulation was more prominent during cholangiocytic differentiation than during 
hepatocytic differentiation. Although high levels of both H3K4me3 and H3K27me3 were 
detected at the Sox4 promoter in purified Dlk+ cells, only H3K4me3 levels were increased 
at the Sox4 locus in terminally differentiated cells (Figure 3(c)). These findings indicate 
that the Sox4 expression level is tightly regulated through histone modifications in both 
stem/progenitor and terminally differentiated cells. 
 
3.6. Loss-of-function assays of Sox4 in hepatic stem/progenitor cells 
Quantitation ofSox4 mRNA extracted from fetal, neonatal, and adult livers using real-
time RT-PCR demonstrated that the Sox4 expression achieved a peak in late-gestational 
fetal liver and decreased rapidly after that (Figure 4(a)). These findings indicated the 
possibility that derepression of Sox4 was essential for the normal differenti- ating process. 
These results prompted us to test the effects ofSox4 in a loss-of-function assay. Sox4 
knockdown was con- firmed using Western blotting (Figure 4(b)). Sox4 knock- down 
impaired colony formation and reduced both the number of large colonies containing 
>100 cells and the size of colonies (Figure 4(c)). Immunocytochemical analyses revealed 
an increase in the number of Alb+CK7+ bipotent cells in colonies derived from Sox4-
depleted Dlk+ cells compared with the findings in control colonies on day 5 of culturing 
(Figures 4(d) and 4(e)). However, no remarkable differences were observed in a number 
ofCasp3-positive cells in control and Sox4-knockdown colonies (Figure 4(f)). In addition, 
Sox4 knockdown resulted in a modest but signifi- cant increase in Sox9 mRNA 
expression (Figure 4(g)). Taken together, Sox4 is essential for the differentiation of Dlk+ 
cells into mature hepatocytes and cholangiocytes. To selectively induce terminal 
hepatocyte maturation, 
we cultured Dlk+ cells in EHS gel supplemented with OSM. Multiple cell clusters with 
tight cell-cell contact were formed by day 4 of culturing. Compared with the findings for 
the control clusters, the Sox4-knockdown clusters lacked hepatocytes with highly 
condensed, granulated cyto- sol and clear round nuclei (Figure 4(h)). Concordant with 
these findings, real-time RT-PCR analyses revealed that hepatocyte-lineage markers, 
such as Alb, tyrosine amino- transferase (Tat), hepatocyte nuclear factor 3β (Hnf3β), and 
Hnf4α, were significantly downregulated in Sox4-de- pleted cells (Supplementary Figure 
S3(a)). In contrast, stem cell markers, such as alpha-fetoprotein (Afp), epithelial cell 
adhesion molecule (Epcam), and Bmi1, were significantly upregulated in Sox4-
knockdown cells. Next, Dlk+ cells were 
cultured on collagen type I gel in the presence of TNF-α to selectively induce 
cholangiocytic differentiation. Sox4- depleted Dlk+ cells, but not control Dlk+ cells, 
failed to form tube-like structures (Figure 4(e)). As expected, real-time RT-PCR analyses 
demonstrated that cholangiocyte-lineage markers, such as CK7, integrin b4 (Itgb4), 
Hnf1β, and Hnf6, were significantly downregulated, and stem cell markers mentioned 
above were upregulated in Sox4-depleted cells (Supplementary Figure S3(b)). Taken 
together, Sox4 gene activation is essential for terminal differentiation toward the 
hepatocyte 
Discussion 
 
Bivalent domains simultaneously contain the opposing histone modifications H3K4me3 
and H3K27me3 and have been found in the promoters of a broad range of genes that 
regulate differentiation in ES cells [19, 20]. This elegant mechanism maintains the cell’s 
undifferentiated state while permitting target gene expression to be rapidly activated or 
repressed when cell fate is determined by differentiation signals [21]. Bivalent domains 
are intimately involved in the balance between TrxG and PcG histone modification. In 
fact, ES cells lacking components of the PcG complex reportedly lose the H3K27me3 
histone modification, leading to de-repression of bivalent genes [22, 23]. Hence, the 
undifferentiated state of ES cells is lost, and differentiation accelerates toward a certain 
cell lineage. Deficits in pluripotency and abnormal differentiation have also been reported 
in tissue-specific stem cells lacking Ezh2 [24, 25]. We previously reported that depleting 
Ezh2 in hepatic stem/progenitor cells eliminates their capacity to self-renew and causes 
them to exhibit abnormal differentiation that is skewed toward the hepatocyte lineage [13]. 
This suggests that PcG plays an important role in repressing differentiation programs in 
stem/progenitor cells. 
Recently, the popularization of the ChIP-seq analysis, which combines next-generation 
sequencers with ChIP, has facilitated comprehensive analyses to determine binding sites 
for transcription factors or enrichments for specific histone modifications [26]. However, 
few reports have comprehensively analyzed histone modifications in stem/progenitor 
cells. In the current study, we first performed ChIP-seq analyses using purified Dlk+ cells 
and antibodies against H3K4 me3 and H3K27 me3. We identified 562 bivalent genes. Of 
these genes, 26 overlapped with bivalent genes in ES cells, 11 overlapped with bivalent 
genes in hematopoietic stem cells, and 3 were common to both. Overall, this is not a large 
number of overlapping genes; this suggests that the epigenetic mechanisms of regulating 
expression through histone methylation vary among cell types. 
Next, we integrated ChIP-seq and microarray data to identify bivalent genes that are 
de-repressed when differentiation is induced. Our results indicated that 72 genes were 
commonly upregulated during differentiation toward both the hepatocyte and 
cholangiocyte lineages. In fact, one of the genes was Ink4a/Arf, which is an important 
PcG target gene. We previously reported that de-repression of the Ink4a/Arf locus in 
Bmi1−/− Dlk+ cells leads to impaired growth activity and self-renewal [18]. Conversely, 
Ink4a/Arf−/− Dlk+ cells exhibit remarkable stem/progenitor cell expansion. Similarly, we 
believe that the 72 genes cited in this study must be repressed to maintain pluripotency in 
hepatic stem/progenitor cells and that they must be transcriptionally activated via the loss 
of repressive histone modifications for normal differentiation to proceed. 
The 72 aforementioned genes include Sox4 and Sox11. Sox genes are transcription 
factors belonging to the HMG box superfamily. Some Sox genes are conserved across 
species, ranging from zebrafish to humans [27]. As their name suggests, Sox genes 
display homology to the DNA-binding HMG box domain of the sex-determination gene 
Sry (generally greater than 50% homology within the HMG box), and to date, more than 
20 different Sox genes have been cloned from mice [28]. Sox4 plays an important role in 
regulating differentiation in neural stem and hematopoietic stem/progenitor cells; 
however, its function in hepatic stem/progenitor cells is unclear [29, 30]. Therefore, we 
performed a more detailed analysis of Sox4. Although Sox4 expression in Dlk+ cells was 
extremely low, levels of the transcriptionally repressive H3K27me3 histone modification 
decreased as the cells were induced to differentiate into hepatocytes and cholangiocytes, 
thereby leading to 20- and 33-fold increases in Sox4 expression, respectively. Lentiviral-
knockdown of Sox4 in Dlk+ cells impaired terminal differentiation towards hepatocyte 
and cholangiocyte lineages and causes an increase in Alb+CK7+ progenitor cells in Dlk+ 
cells–derived colonies. Concordant with these findings, Poncy and colleagues reported 
that cholangiocyte differentiation and bile duct formation are perturbed in developing 
livers in Sox4-knockout mice [31]. Further analyses are necessary to elucidate the role of 
Sox4 in the regulation of hepatic stem/progenitor cells. 
In addition, Kawaguchi and colleagues reported that based on a genetic lineage tracing 
analysis in mice, hepatocytes and cholangiocytes differentiate from Sox9-negative 
hepatoblasts [32]. In the current study, the H3K27me3 modification at the Sox9 locus was 
slightly below the cutoff, and it was therefore not included as a bivalent gene. However, 
Sox9 expression in Dlk+ cells was extremely low, and we observed a greater than 5-fold 
increase in its expression after the induction of differentiation into hepatocytes or 
cholangiocytes. We previously revealed that Sox17 is a target of Bmi1 and that its 
overexpression in Dlk+ cells accelerates their differentiation [18]. These examples 
illustrate that Sox genes in Dlk+ cells are finely controlled at the transcriptional level via 
histone modifications and suggest that they play important roles in controlling the 
differentiation of hepatic stem/progenitor cells. 
Finally, our findings demonstrated that several genes possess bivalent histone marks in 
hepatic stem/progenitor cells. Additionally, drastic changes in the expression of these 
genes caused by the loss of bivalent domains are closely associated with the normal 
differentiation process. Further analyses are necessary to determine the roles of the 
identified genes in hepatic stem cell systems. 
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Figure Legends 
 
Figure 1 ChIP-seq analyses of freshly isolated Dlk+ cells.  
(a) Distribution of H3K4me3- or H3K27me3-bound probes in the promoter regions (from 
-2 Kb to +2 Kb of the TSS). (b) Summary of H3K4me3 or H3K27me3 enrichment 
detected by ChIP-seq analyses. (c) Venn diagram showing the number of genes with 
H3K4me3 and/or H3K27me3 modifications with fold enrichment >2 (log2). (d) Overlap 
of bivalent genes among the histone modification profiles in ES cells reported by 
Bernstein et al. [16] and hematopoietic stem cells reported by Weishaupt et al. [17]. (e) 
GO analyses of genes marked with both H3K4me3 and H3K27me3. 
 
Figure 2 Correlation between histone marks and gene expression level and identification 
of bivalent genes showing de-repression after differentiation induction. (a) Pearson's 
correlation coefficient analysis revealed that the levels of H3K4me3 enrichment were 
positively correlated with gene expression levels (r = 0.57). By contrast, levels of 
H3K27me3 enrichment were inversely correlated with gene expression levels (r = -0.24). 
(b) Box plot showing the 25th, 50th, and 75th percentiles of expression for genes with 
different histone modifications. (c) Scatter diagrams of the microarray analysis. 
Alterations in gene expression following hepatocytic differentiation in response to OSM 
and cholangiocytic differentiation in response to TNF-α were analyzed via microarray-
based expression analysis. The red and green lines represent the borderline for the 2-fold 
increases and decreases, respectively. (d) Venn diagram depicted the number of bivalent 
genes showing de-repression after differentiation induction. 
 
Figure 3 Histone modification status at the Sox4 locus in purified Dlk+ cells and 
terminally differentiated cells.  
(a) Signal map of H3K4me3 and H3K27me3 at the Sox4 locus in Dlk+ cells. (b) Real-
time RT-PCR analysis of Sox4 in Dlk+ cells and cells differentiated toward hepatocye and 
cholangiocyte lineages. *Statistically significant (p <0.05). (c) Quantitative ChIP 
analyses of the Sox4 locus and Actb control promoter region using anti-H3K4me3 and 
anti-H3K27me3 antibodies. Percentages of input DNA are shown as mean values for 
independent triplicate analyses.  
 
Figure 4 Loss-of-function assays of Sox4 in Dlk+ cells.  
(a) Western blot analyses in Sox4-knockdown cells using anti-Sox4 and anti-tubulin 
(loading control) antibodies. (b) Fluorescence micrographs of large colonies (containing 
>100 cells) transduced with indicated viruses at day 5 of culture. Dual immunostaining 
was performed to detect Alb (red) and CK7 (green) expression. Nuclear DAPI staining 
(blue) is shown in the insets. Scale bar = 200 μm. (c) The number of large colonies 
containing >100 cells at day 5. *Statistically significant (p <0.05). (d) The percentages of 
Alb+CK7+ bipotent cells in large colonies at day 5 of culture are shown as mean values 
for 10 colonies. *Statistically significant (p <0.05). (e) Bright-field images and 
fluorescence micrographs (inset panels) of cells in EHS gel culture for hepatocytic 
differentiation and collagen gel culture for cholangiocytic differentiation. Scale bar = 100 
μm. (f) Immunostaining analyses demonstrated Casp3 (red) and nuclear DAPI (blue). 
Scale bar = 200 μm. (g) Real-time RT-PCR analysis of Sox9 in Dlk+ cell-derived colonies. 
∗Statistically significant (P <0 05). (h) Bright-field images and fluorescence micrographs 
(inset panels) of cells in EHS gel culture for hepatocytic differentiation and collagen gel 
culture for cholangiocytic differentiation. Scale bar = 100 μm. 
 
 
 
  
   
   
   
   
Supplementary Table S1 Primer sequences for Quantitative RT-PCR 
Gene name Forward primer (5'-3’)   Reverse primer (5'-3’)   
p16Ink4a   AATCTCCGCGAGGAAAGC GTCTGTCTGCAGCGGACTC 
p19Arf  GGGTTTTCTTGGTGAAGTTCG TTGCCCATCATCATCACCT 
Hnf1b    CTACGACCGGCAAAAGAATC CCCCTCGTTGCAAACATT 
Hnf3b  CAACCACCCCTTCTCTATCAA CCTTGAGGTCCATTTTGTGG 
Hnf4a  GCGGAGGTCAAGCTACGA ATCCCAGAGATGGGAGAGGT 
Hnf6   AGACCTTCCGGAGGATGTG TTGCTCTTTCCGTTTGCAG 
Alb  TGGAATGCGCAGATGACA GTGGTTTATCGCAGCAAGTCT 
CK7  CATTGAGATCGCCACCTACC ACAGGTCCCATTCCGTCTC 
Itgb4  GAGGATTCATCCAACATCGTG CGGATGTCCAGGTTGGAG 
Tat  CGGAGCAGTCTGTCCACTG GAACTCCTGGATCCGGCTA 
Sox4  CTCGCTCTCCTCGTCCTCT CGTCTTCGAACTCGTCGTC 
Sox9  GTACCCGCATCTGCACAAC CTCCTCCACGAAGGGTCTCT 
Hprt  TCCTCCTCAGACCGCTTTT CCTGGTTCATCATCGCTAATC 
 
Supplementary Table S2 Primer sequences designed for ChIP quantitative PCR 
Region   Sequence 
Sox4-1    Fw 5'- TTTGCCTCTGTGTGTGTGTG -3' 
   Rv 5'- CCTCCAAGCCCCTTGTTATC -3' 
Sox4-2   Fw 5'- AATTGCACCAACTCCTCAGC -3' 
   Rv 5'- TCGATTGCAGTTCACGAGAG -3' 
Sox4-3   Fw 5'- ACAGCGACAAGATTCCGTTC -3' 
Rv 5'- GCCCGACTTCACCTTCTTTC -3' 
Sox4-4   Fw 5'- CTCTCCTCGTCCTCTTCCTC -3' 
   Rv 5'- CAAAGTTTGAGCTGGGGTTC -3' 
Ink4a/Arf-1  Fw 5'- CTTAGAGTTACAGAAAGGGCTGGA -3' 
   Rv 5'- GAATTTCAAGGAAGTGCTACCCTA -3' 
Ink4a/Arf-2  Fw 5'- CACTGCACTGGAAGAGGACA -3' 
   Rv 5'- CTGAAGGTCCTGGGTTCAAA -3' 
Ink4a/Arf-3  Fw 5'- GATGGAGCCCGGACTACAGAAG -3' 
   Rv 5'- CTGTTTCAACGCCCAGCTCTC -3' 
Ink4a/Arf-4  Fw 5'- AGGGAATACACTGTAAGCCTGTGT -3' 
   Rv 5'- TTAACTACTCGGATCAGACATCCA -3' 
Actb   Fw 5'- CCCAACACACCTAGCAAATTAGAACCAC -3' 
   Rv 5'- CCTGGATTGAATGGACAGAGAGTCACT -3' 
 
  
Supplementary Table 3 List of bivalent genes showing upregulation after differentiation 
induction 
RefSeq Definition 
Adcy1 adenylate cyclase 1 
Ap1s2 AP-1 complex subunit sigma-2 
Ap3m2 adaptor related protein complex 3 mu 2 subunit 
Bmper BMP binding endothelial regulator  
Cbr3 carbonyl reductase 3 
Ccdc92 coiled-coil domain containing 92 
Cdkn2a Cyclin dependent kinase inhibitor 2A 
Cdr2l Cerebellar degeneration related protein 2 like 
Celsr1 Cadherin EGF LAG seven-pass G-type receptor 1 
Crim1 Cysteine rich transmembrane BMP regulator 1  
Cyb561 Cytochrome b561 
Dlgap4 DLG associated protein 4 
Enah ENAH, actin regulator 
Eomes Eomesodermin 
Eps8 Epidermal growth factor receptor pathway substrate 8 
Fam171b Family with sequence similarity 171 member B 
Fam189a2 Family with sequence similarity 189 member A2  
Fam84a Family with sequence similarity 84 member A 
Fbxo2 F-box protein 2 
Fibcd1 Fibrinogen C domain containing 1 
Flnc Filamin C 
Fzd9 Frizzled class receptor 9 
Gabbr1 Gamma-aminobutyric acid type B receptor subunit 1 
Galnt12 Polypeptide N-acetylgalactosaminyltransferase 12 
Grasp General receptor for phosphoinositides 1 associated scaffold protein 
Hap1 Huntingtin associated protein 1 
Hs3st6 Heparan sulfate-glucosamine 3-sulfotransferase 6 
Htra1 HtrA serine peptidase 1 
Insm1 INSM transcriptional repressor 1 
Irx3 Iroquois homeobox 3 
Kcnj4 Potassium voltage-gated channel subfamily J member 4 
Kcns3 Potassium voltage-gated channel modifier subfamily S member 3 
Kif5c Kinesin family member 5C 
   
Klf5 Kruppel like factor 5 
Loxl1 Lysyl oxidase like 1 
Mal Mal, T cell differentiation protein 
Supplementary Figure Legends 
 
Supplementary Figure S1 Purification of hepatic stem/progenitor cells. Representative 
flow cytometric profiles of MACS-sorted Dlk+ cells. The percentages of Dlk+ cells are 
indicated as mean values for three independent analyses. 
 
Supplementary Figure S2 Histone modification status at the Ink4a/Arf loci in purified 
Dlk+ and terminally differentiated cells. 
(A) The signal map of H3K4me3 and H3K27me3 at the Ink4a/Arf locus in Dlk+ cells. (B) 
Real-time RT-PCR analysis of Ink4a/Arf in Dlk+ cells and cells differentiated toward 
hepatocye lineage and cholangiocyte lineages. *Statistically significant (P <0.05). (C) 
Quantitative ChIP analyses on the Ink4a/Arf loci and Actb control promoter region using 
anti-H3K4me3 and anti-H3K27me3 antibodies. Percentages of input DNA are shown as 
mean values for independent triplicate analyses. 
 
Supplementary Figure S3 Effects of Sox4-knockdown on the differentiation of hepatic 
stem/progenitor cells.  
(A) Real-time RT-PCR analyses of hepatocytic differentiation and maturation marker 
genes. (B) Real-time RT-PCR analyses of cholangiocytic differentiation and maturation 
marker genes. 
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